Barr, Frederick E.,Summar, Marshall L.,Christman, Brian
申请号：
AU2009203177
公开号：
AU2009203177B2
申请日:
2009.07.31
申请国别(地区):
AU
年份:
2012
代理人:
摘要：
#$%^&*AU2009203177B220120322.pdf#####Abstract of the Disclosure Isolated polynucleotide molecules and peptides encoded by these molecules are used in the analysis of human carbamyl phosphate synthetase I phenotypes, as well as in diagnostic and therapeutic applications, relating to a 5 human carbamyl phosphate synthetase I polymorphism. By analyzing genomic DNA or amplified genomic DNA, or amplified cDNA derived from mRNA, it is possible to type a human carbamyl phosphate synthetase I with regard to the human carbamyl phosphate synthetase I polymorphism, for example, in the context of diagnosing and treating hepatic veno-occlusive disease (HVOD) 10 associated with bone marrow transplants. -116-1/13 MItochondrio HCO:+NHA+ 2AT P CPSI -.- ~*.N-acetylglutate CorbamoAsportic PhoshateOTCAcid OmithineArginosuccinote ARG nneI ASL Urea Agne Fumorote FIG, I CO AI0 /b -V . '；a 44 .v -P d~/ Q ~. 0) ~,FIG, 2
